Skip to main content

International Flavors & Fragrances company profile

  • IFF · NYSE
  • Chemicals
  • Specialty Chemicals
  • S&P 500
$81.16+0.97%Close 13 Nov 2026 · Market value $20.08B

About International Flavors & Fragrances

International Flavors & Fragrances creates and manufactures products for food, beverage, health & biosciences, and scent applications, along with adjacent products including natural health ingredients. Its products are sold principally to manufacturers in categories such as dairy, meat, beverages, snacks, baked goods, personal care, soaps and detergents, perfumes, dietary supplements, and animal nutrition. Its operating segments in 2025 were Taste, Food Ingredients, Health & Biosciences, and Scent, with Pharma Solutions included until its divestiture in May 2025. In 2025, U.S. sales represented approximately 28% of total sales of $10.890 billion, and no customer accounted for 10% or more of sales. The company operates approximately 170 manufacturing facilities, creative centers and application laboratories in about 30 countries.

A summary of the business section of the company's latest annual report, filed 27 Feb 2026.

Company facts

TickerIFF · NYSE
SectorChemicals
IndustrySpecialty Chemicals
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK51253
Latest annual report10-K, filed 27 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Paul J. FribourgDirector2.3M · < 1%Open-market purchase, 1 Jun 2026
J. Erik FyrwaldChief Executive Officer · Director123K · < 1%Option exercise, 1 May 2026
Jennifer JohnsonEVP, General Counsel31.0K · < 1%Shares withheld for tax, 4 Mar 2025
Kevin O’ByrneDirector27.2K · < 1%Option exercise, 1 May 2026
Yuvraj AroraPresident, Taste & CCO21.3K · < 1%Option exercise, 1 May 2026
Michael DeVeauEVP, CFO19.0K · < 1%Open-market sale, 6 Aug 2026
Mark J. CostaDirector6.6K · < 1%Option exercise, 1 May 2025
Andres MullerPresident, Food Ingredients3.8KOption exercise, 1 Apr 2026
Mehmood KhanDirector3.2K · < 1%Option exercise, 1 May 2026
Vincent IntrieriDirector3.2K · < 1%Option exercise, 1 May 2025
Cynthia T. JamisonDirector3.2K · < 1%Option exercise, 1 May 2025
Virginia C. DrososDirector2.4K · < 1%Option exercise, 1 May 2026
Brett IcahnDirector1.7K · < 1%Option exercise, 1 May 2026
Richard MulliganDirector1.7K · < 1%Option exercise, 1 May 2026
Teles de Mendonca Ana PaulaPresident, Scent—Open-market sale, 17 Aug 2026
Birenkrant MarcController & CAO—Open-market sale, 7 Aug 2026
Finzel RalfEVP, Global Operations Officer—Option exercise, 4 May 2026
Borg DeborahEVP, Chief Ppl&Culture Officer—Option exercise, 4 May 2026
Lourenco Leticia GoncalvesPresident, Health & Bioscience—Shares withheld for tax, 1 Apr 2026
Landsman Stephen NEVP, General Counsel—Option exercise, 1 Apr 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

IFF in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.